BioMimir Selected for Prestigious MedTech Innovator 2025 Accelerator Cohort

BioMimir, a medical device company focused on regenerative medicine, announced today that it has been selected to join the MedTech Innovator 2025 Accelerator Cohort. BioMimir is one of only 65 companies—representing the top 4% of nearly 1,500 global applicants—chosen for this year’s program.